BioCentury
ARTICLE | Company News

FDA issues handful of new PDUFA dates

February 19, 2019 10:39 PM UTC

With the government shutdown resolved, FDA has accepted a handful of applications for review, according to company announcements early this week.

FDA granted Priority Review to two applications from Genentech Inc. for entrectinib and polatuzumab vedotin...